Raymond James Financial’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.6M Buy
336,662
+234,849
+231% +$9.47M ﹤0.01% 1766
2026
Q1
$3.32M Sell
101,813
-19,790
-16% -$643K ﹤0.01% 2935
2025
Q4
$3.98M Sell
121,603
-32,275
-21% -$794K ﹤0.01% 2691
2025
Q3
$2.75M Sell
153,878
-1,305
-0.8% -$18.9K ﹤0.01% 2922
2025
Q2
$1.68M Sell
155,183
-98,946
-39% -$1.3M ﹤0.01% 3219
2025
Q1
$4.7M Sell
254,129
-22,071
-8% -$398K ﹤0.01% 2375
2024
Q4
$4.55M Buy
+276,200
New +$3.91M ﹤0.01% 2385

Other funds holding AXGN

Raymond James Financial's AXGN Position: Q2 2026 in Review

Raymond James Financial increased its Axogen (AXGN) stake by 231% in Q2 2026, buying an estimated $9.47M and bringing the position to 336,662 shares worth $15.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1766.

Raymond James Financial first reported a position in AXGN in Q4 2024 and has held it in 7 quarters since. 253 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

  • Raymond James Financial held 336,662 shares of Axogen worth $15.6M as of Q2 2026.
  • Raymond James Financial bought 234,849 Axogen shares in Q2 2026, an estimated $9.47M.
  • Axogen made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1766 holding.
  • Raymond James Financial first reported a position in Axogen in Q4 2024 and has held it in 7 quarters since.
  • 253 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.